A New Paradigm for Drug Discovery
Posted on | May 16, 2013 | Comments Off
“Crowdfunding has revitalized project financing. Science is next. Crowdfunding is the newest innovation in financing, all thanks to the unprecedented access to information through the Internet.
Rare Genomics Institute is helping children with rare disease. PetrDish and Microryza are finding funding for research. Community laboratories are opening up to allow amateur scientists to test their ideas cheaply. more…“
NOVARTIS AG VERSUS UNION OF INDIA
Posted on | April 2, 2013 | Comments Off
IN THE SUPREME COURT OF INDIA
CIVIL APPELLATE JURISDICTION
CIVIL APPEAL Nos. 2706-2716 OF 2013
(ARISING OUT OF SLP(C) Nos. 20539-20549 OF 2009)
NOVARTIS AG ….APPELLANT
VERSUS
UNION OF INDIA & OTHERS ….RESPONDENTS
more…
New Tools in the War on Cancer
Posted on | March 19, 2013 | Comments Off
“Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly than blood vessels, so these unruly masses of cells receive very little oxygen and nutrients, which means they know just how to survive under harsh conditions. They make miniature pumps to actively dispel anything that doesn’t serve them well (like drugs), and … more“
India revokes patent on Merck & Co asthma drug
Posted on | December 12, 2012 | Comments Off
“India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co (MRK.N), citing lack of invention, after Indian drugmaker Cipla Ltd (CIPL.NS) challenged an earlier decision.”
“The move is the latest in a series of patent cancellations by India, where …http://in.reuters.com/article/2012/12/11/india-merck-patent-idINDEE8BA09Y20121211“
Ameridose’s 483
Posted on | November 14, 2012 | Comments Off
I just read Ameridose’s 483.
FDA Urged to Speed Approval of Drugs
Posted on | September 28, 2012 | Comments Off
“A White House advisory body on Tuesday unveiled a plan to double the number of new prescription drugs that go on the market each year by more quickly approving drugs to treat high-risk patients.
The President’s Council of Advisors on Science and Technology urged the Food and Drug Administration to expand its use of faster drug approvals to a wider range of diseases. The council suggested the FDA could begin to approve drugs that may help only a narrow and high-risk patient population, such as people who are morbidly obese, under what the council called “special medical use” approvals.
The advisory report gave few details of what new laws or …more“
keep looking »Recommended Vendors
FDA What’s New
World Pharma
- Aspirin may fight cancer by slowing DNA damage
- MedImmune, AstraZeneca's biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
- FDA approves Amgen's XGEVA® (denosumab) for the treatment of giant cell tumor of bone
- Bristol-Myers Squibb and Simcere enter partnership to co-develop and co-commercialize Orencia® SC (abatacept) in China